Actively Recruiting
Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?
Led by Ziekenhuis Oost-Limburg · Updated on 2024-11-15
300
Participants Needed
1
Research Sites
141 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
During direct anterior approach (DAA) for total hip arthroplasty (THA), ligation of the lateral femoral circumflex artery and vessel is always conducted. However, this standardized procedure may jeopardize blood muscle perfusion and cause tenderness in the tensor fascia lata muscle. The investigators want to investigate whether blood vessel-sparing surgery is feasible, reproducible, and would alter outcomes following DAA THA. The surgical technique of the vessel-sparing procedure will be described and investigated in a prospective blinded RCT. The investigators hypothesize that the vessel-sparing technique is feasible in 60% of the patients. If these vessels were not sacrificed, the investigators expect the incidence of TFL tendinopathy to be lower.
CONDITIONS
Official Title
Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for total hip arthroplasty (THA) by Dr. Frans-Jozef Vandeputte or Professor Dr. Kristoff Corten
- Provided signed and dated informed consent
- Male or female aged over 18 years
You will not qualify if you...
- Neurological problems with sensory or motor disturbances such as Multiple Sclerosis, Parkinson's disease, or hemiplegia
- Previous surgery on the same side hip
- Fracture of the neck of the femur on the same side
- Previous total hip arthroplasty on the opposite side
- Significant hip deformity including Crowe type 3 and 4 dysplasia or Leg-Calvé-Perthes disease
- Avascular necrosis of the femoral head
- Currently participating in another study that could interfere with this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600
Actively Recruiting
Research Team
F
Frans-Jozef Vandeputte, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here